FDA issues EUA for test differentiating flu from COVID-19

Jul 06, 2020 - 03:29 PM
fda-product-update

The Food and Drug Administration the emergency use of a third diagnostic test that detects and differentiates flu and COVID-19 viruses from one another. 

The test from the Centers for Disease Control and Prevention, along with previously authorized tests from BioFire Diagnostics LLC and QIAGEN GmbH, require only a single sample from patients who exhibit respiratory disease symptoms. FDA said these tests will use fewer supplies and provide faster and comprehensive results.

Related News Articles

Headline
Nevada confirms its first human case of bird flu
The Central Nevada Health District yesterday announced the state's first case of H5N1 bird flu, a dairy farm worker who was exposed to infected cattle. The…
Headline
CDC estimates at least 24 million have had seasonal flu 
At least 24 million people have had seasonal flu this season, according to estimates  from the Centers for Disease Control and Prevention. Nearly 49,000…
Headline
CDC: Flu activity remains high, COVID-19 increasing while RSV peaks 
Respiratory illness activity remains high across the country, according to the latest data from the Centers for Disease Control and Prevention. Seasonal flu…
Headline
CDC alerts clinicians to accelerate type A flu subtyping in hospitalized patients
The Centers for Disease Control and Prevention today released an advisory recommending clinicians expedite subtyping of type A influenza samples from…
Headline
Louisiana reports first H5N1 bird flu death in U.S.
The Louisiana Department of Health yesterday announced that a patient hospitalized last month for H5N1 bird flu has died, becoming the first U.S. death from…
Headline
Latest United Against the Flu toolkit urges vaccination during peak respiratory virus season 
AHA’s latest social media toolkit for encouraging vaccination against the flu and COVID-19 focuses on vaccination during peak respiratory virus season. The…